Sunrest Lifescience (NSE:SUNREST) Institutional Ownership: 0.00% (As of Aug. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SUNREST Sunrest Lifescience Ltd NSE:SUNREST
44 GF Score
Price ₹40.50
! 5 Warning Signs
View Full Analysis

What is Sunrest Lifescience Institutional Ownership?

Sunrest Lifescience NSE:SUNREST +3.85% 44 Institutional Ownership is 0.00% as of Aug. 10, 2026. GuruFocus rates NSE:SUNREST with a GF Score™ of 44/100. The stock has 5 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Sunrest Lifescience's institutional ownership is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Sunrest Lifescience's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Sunrest Lifescience's Float Percentage Of Total Shares Outstanding is 0.00%.

Sunrest Lifescience Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Sunrest Lifescience's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunrest Lifescience Institutional Ownership Chart

Sunrest Lifescience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Institutional Ownership
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Sunrest Lifescience Semi-Annual Data
Mar20 Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Mar26
Institutional Ownership Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:SUNREST
44GF Score
Sunrest Lifescience Ltd NSE:SUNREST
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunrest Lifescience Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.00% mean?
Sunrest Lifescience (NSE:SUNREST) has a Institutional Ownership of 0.00% as of Aug. 10, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Sunrest Lifescience and its competitors.
Is Sunrest Lifescience's Institutional Ownership too high?
Sunrest Lifescience's current Institutional Ownership is 0.00%. Overall, Sunrest Lifescience has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Sunrest Lifescience's Institutional Ownership compare to competitors?
Sunrest Lifescience's Institutional Ownership of 0.00% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Healthcare Providers & Services company?
A good Institutional Ownership depends on the Healthcare Providers & Services industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Sunrest Lifescience and its competitors. Sunrest Lifescience's current Institutional Ownership is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunrest Lifescience stock overvalued right now?
Sunrest Lifescience (NSE:SUNREST) has a current Institutional Ownership of 0.00%. The current Institutional Ownership is 0.00%. Sunrest Lifescience's overall GF Score™ is 44/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Sunrest Lifescience (NSE:SUNREST), the current Institutional Ownership is 0.00% as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sunrest Lifescience Business Description

Address YMCA Club, Near SG Highway, D-608 West Gate, Near Brooklin Tower, Makarba, Jivraj Park, Ahmedabad, GJ, IND, 380051
Sunrest Lifescience Ltd is engaged in the trading business of pharmaceutical products, including capsules, tablets, syrups, ointments, gels, mouthwash, and toothpaste on a wholesale and retail basis. Its product portfolio covers categories such as anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental care, anti-inflammatory, nutraceuticals, and more. The company works with a network of suppliers and super suppliers, distributing products to chemists, hospitals, and dispensaries across multiple Indian states. Sunrest relies on both in-house manufacturing through its group company Trilend Pharmaceuticals and third-party manufacturers, emphasizing quality control and regulatory compliance.
44GF Score

Get the complete analysis for NSE:SUNREST

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹40.50
Price